This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: University of Florida Research Foundation Inc., Banyan Biomarkers, Inc.. Active years: 2008-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 3,052 
3 out of 15 Years Active: 2008-2013
Title: The Innovations of Ming Chen Liu
Introduction
Ming Chen Liu is a notable inventor based in Gainesville, FL (US). He has made significant contributions to the field of biomedical research, particularly in the area of traumatic brain injury and diagnostic biomarkers. With a total of 4 patents, his work has the potential to impact both clinical practices and patient outcomes.
Latest Patents
Ming Chen Liu's latest patents include groundbreaking research on synaptotagmin and collapsin response mediator proteins as biomarkers for traumatic brain injury. His findings indicate that collapsin response mediator proteins (CRMPs) decrease in tissue and increase in biological fluids following neural injury from traumatic brain injury (TBI). Notably, significant decreases of CRMP1, CRMP2, CRMP4, and CRMP5 were observed, accompanied by the emergence of distinct breakdown products from proteolytic cleavage by calpain. Additionally, synaptotagmin breakdown products were associated with TBI and could be detected alongside intact protein in human cerebral spinal fluid (CSF). Both biomarkers were identified in human biofluid and are related to recovery from traumatic brain injury. Another patent focuses on proteolytic markers as diagnostic biomarkers for cancer, organ injury, and muscle rehabilitation/exercise overtraining. This invention identifies biomarkers that are diagnostic of nerve cell injury, organ injury, and/or neuronal disorders, providing insights into the severity and localization of injuries.
Career Highlights
Ming Chen Liu has worked with esteemed organizations such as the University of Florida Research Foundation Inc and Banyan Biomarkers, Inc. His research has contributed to advancements in understanding and diagnosing traumatic brain injuries and other neurological conditions.
Collaborations
Ming Chen Liu has collaborated with notable individuals in his field, including Ronald L Hayes and Monika Oli. These partnerships have further enhanced the impact of his research and innovations.
Conclusion
Ming Chen Liu's contributions to the field of biomedical research, particularly in the area of traumatic brain injury and diagnostic biomarkers, highlight his innovative spirit and dedication to improving patient care. His work continues to pave the way for future advancements in medical diagnostics and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile